title: Early development of lactic acidosis with short term linezolid treatment in a renal recipient.
authors.forename: Y R
authors.initials: YR
authors.lastname: Lee
authors.forename: N
authors.initials: N
authors.lastname: Powell
authors.forename: H
authors.initials: H
authors.lastname: Bonatti
authors.forename: R G
authors.initials: RG
authors.lastname: Sawyer
authors.forename: L
authors.initials: L
authors.lastname: Barroso
authors.forename: T L
authors.initials: TL
authors.lastname: Pruett
authors.forename: C D
authors.initials: CD
authors.lastname: Sifri
authors.forename: D
authors.initials: D
authors.lastname: Volles
mesh_terms: D000081:Acetamides / Q000009:adverse effects*; D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D000890:Anti-Infective Agents / Q000009:adverse effects*; D016971:Citrobacter freundii; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D000069349:Linezolid; D000077731:Meropenem; D008875:Middle Aged; D023303:Oxazolidinones / Q000009:adverse effects*; D013845:Thienamycins / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000276:immunology
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D013845:Thienamycins; D000077731:Meropenem; D000069349:Linezolid